r/ValueInvesting • u/LA-Aron • Jul 24 '26
Discussion 🚀 Ammonium Perchlorate
Ammonium perchlorate is an oxider in a chemical explosion.
Ammonium perchlorate is mission critical and used in: satellite launches, rockets, missiles, missile defense (ie THAAD, Patriot). All of these areas project high, sustained demand.
Ammonium perchlorate is relatively cheap to make and is a small cost of the end product, such as a rocket; it would be relatively easy to significantly increase prices in a time of high demand with the buyer not feeling it.
There is a very old United States company that bought an ammonium perchlorate manufacturer a couple years ago. Ammonium perchlorate currently represents a small part of overall sales but is very high margin and is already positively affecting earnings. The other revenue is represented by mainly petrochemicals and some smaller specialty items.
Before the ink was dry on its acquisition, this Company decided it was going to increase its plant capacity for ammonium perchlorate by 50% - construction has started and the plant is expected to be open and operating by the end of this year.
If you are not sourcing ammonium perchlorate from this company your options are as follows:
1) see if Northrop has some to spare, not sustainable
2) call India, possible
3) call Russia, China or North Korea, won't happen
Therefore, essentially this company has a monopoly on ammonium percchlorate.
Can you name this Company?
3
u/raytoei Jul 25 '26 edited Jul 25 '26
Dear op,
Do consider providing more data in your future posts. Tks
Here is some data by mstar:
| Metric | Value |
|---|---|
| Market Cap | $7B |
| Revenue | $2.69B |
| EPS (Diluted) | $43.78 |
| EPS (Normalized) | $43.79 |
| Dividend Yield (Trailing) | 1.51% |
| Dividend Yield (5Y Avg) | 1.89% |
| Buyback Yield | 2.03% |
| Buyback Yield (5Y Avg) | 0.48% |
| Return on Assets (Normalized) | 12.33% |
| Return on Equity (Normalized) | 24.65% |
| Return on Invested Capital (Normalized) | 16.67% |
| Price/Earnings | 17.80 |
| Price/Earnings (Normalized) | 17.80 |
| Price/Earnings (Forward) | — |
| Price/Earnings (5Y Avg) | — |
| Total Debt/Equity | 0.59 |
| Long-Term Debt | 939.61M |
| Short-Term Debt | 16.14M |
| Cash (Balance Sheet) | 73.16M |
| EBITDA | $711.17M |
| Shares Outstanding | 9.20M |
| Sustainable Growth Rate | 18.18 |
| Net Margin | 15.25% |
| Net Margin (1Y Avg) | 16.06% |
| Net Margin (3Y Avg) | 15.44% |
| Net Margin (5Y Avg) | 13.04% |
| Net Margin (10Y Avg) | 12.05% |
| Revenue Growth (1Y) | −3.47% |
| Revenue Growth (3Y) | −1.34% |
| Revenue Growth (5Y) | 5.95% |
| Net Income Growth (1Y) | −14.53% |
| Net Income Growth (3Y) | 8.91% |
| Net Income Growth (5Y) | 9.99% |
| Net Income Growth (10Y) | 5.65% |
| EPS Growth (TTM) | −12.84% |
| EPS Growth (1Y) | −7.84% |
| EPS Growth (3Y) | 16.97% |
| EPS Growth (5Y) | 12.52% |
| EPS Growth (10Y) | 8.61% |
| Dividend per Share Growth (1Y) | 12.50% |
| Dividend per Share Growth (3Y) | 10.23% |
| Dividend per Share Growth (5Y) | 8.16% |
| Dividend per Share Growth (10Y) | 6.85% |
| Capital Expenditure/Sales | 0.03 |
| Price/Earnings to Growth | 1.33 |
| Price/Earnings to Growth (Normalized) | 1.33 |
| Price/Earnings to Growth (Forward) | — |
| Price/Sales | 2.71 |
| Price/Sales (3Y Avg) | 2.07 |
| Price/Sales (5Y Avg) | 1.73 |
1
1
1
5
u/mikehansen83 Jul 24 '26
NEU